Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and the tumour-initiating capability of head-and-neck squamous cell carcinoma cells. The epithelial–mesenchymal transition (EMT), one of the main...

Full description

Saved in:
Bibliographic Details
Published inNature cell biology Vol. 12; no. 10; pp. 982 - 992
Main Authors Yang, Muh-Hwa, Hsu, Dennis Shin-Shian, Wang, Hsei-Wei, Wang, Hsiao-Jung, Lan, Hsin-Yi, Yang, Wen-Hao, Huang, Chi-Hung, Kao, Shou-Yen, Tzeng, Cheng-Hwai, Tai, Shyh-Kuan, Chang, Shyue-Yih, Lee, Oscar Kuang-Sheng, Wu, Kou-Juey
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2010
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and the tumour-initiating capability of head-and-neck squamous cell carcinoma cells. The epithelial–mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1465-7392
1476-4679
1476-4679
DOI:10.1038/ncb2099